BioSenic S.A.
BioSenic S.A. (BIOS) is a Biotechnology company in the Healthcare sector, listed on Euronext Brussel. This page provides the complete earnings calendar, dividend schedule, and financial data for BioSenic S.A. in 2026.
Earnings calendar
Next earnings date
—
Not scheduled
EPS estimate
—
Revenue estimate
—
Past earnings
No earnings history available.
Dividend calendar
No dividend history available.
Company profile
BioSenic S.A., a biotech company, focuses on developing clinical assets. Its technologies include cutting-edge allogeneic cell and gene therapy platform with differentiated bone marrow sourced mesenchymal stromal cells, which can be stored at the point of use in the hospital; and Arsenic TriOxide platform for use in immuno-oncology to treat graft-versus-host disease, systemic lupus erythematosus, and systemic sclerosis. The company's investigational medicinal product is ALLOB, which is in a Phase IIb clinical trial in patients with difficult tibial fractures. The company is based in Mont-Saint-Guibert, Belgium.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- Belgium
- Exchange
- Euronext Brussel
- CEO
- Jean-Luc Vandebroek
- Employees
- 12
- IPO date
- 26 Oct 2022
- ISIN
- BE0974280126
- Website
- biosenic.com
Frequently asked questions
Where is BioSenic S.A. stock listed?
BioSenic S.A. (BIOS) is listed on Euronext Brussel.